Cleveland BioLabs
CBLI
#9803
Rank
S$63.36 M
Marketcap
S$4.09
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Earnings for Cleveland BioLabs (CBLI)

Earnings in 2021 (TTM): -S$3.7 Million

According to Cleveland BioLabs 's latest financial reports the company's current earnings are S$0.63 Million. In 2020 the company made an earning of -S$3.32 Million a decrease over its 2019 earnings that were of -S$3.05 Million.

Earnings history for Cleveland BioLabs from 2004 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-S$3.7 Million11.54%
2020-S$3.32 Million8.8%
2019-S$3.05 Million-50.81%
2018-S$6.2 Million-14.3%
2017-S$7.24 Million-11.88%
2016-S$8.21 Million-50.9%
2015-S$16.72 Million-10.24%
2014-S$18.63 Million-37.5%
2013-S$29.81 Million-23.2%
2012-S$38.81 Million19.68%
2011-S$32.43 Million133.81%
2010-S$13.87 Million68.22%
2009-S$8.25 Million-55.51%
2008-S$18.53 Million-45.62%
2007-S$34.07 Million255.63%
2006-S$9.58 Million198.18%
2005-S$3.22 Million-1.25%
2004-S$3.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-S$23.45 Million 559.60%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-S$0.21 Billion 5,693.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.64 B-299,603.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$21.20 B-596,599.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
S$10.37 B-291,937.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.75 B-330,710.78%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
S$12.03 B-338,799.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-S$15.98 Million 349.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$29.06 B-817,651.66%๐Ÿ‡บ๐Ÿ‡ธ USA